SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050414
Filing Date
2017-08-09
Accepted
2017-08-09 06:05:31
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13361_110q.htm 10-Q 1016803
2 EX-31.1 a17-13361_1ex31d1.htm EX-31.1 13932
3 EX-31.2 a17-13361_1ex31d2.htm EX-31.2 13990
4 EX-32 a17-13361_1ex32.htm EX-32 12420
  Complete submission text file 0001104659-17-050414.txt   3284660

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tbph-20170630.xml EX-101.INS 525719
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbph-20170630.xsd EX-101.SCH 26885
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbph-20170630_cal.xml EX-101.CAL 43815
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbph-20170630_def.xml EX-101.DEF 83682
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tbph-20170630_lab.xml EX-101.LAB 260961
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbph-20170630_pre.xml EX-101.PRE 179002
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 171016326
SIC: 2834 Pharmaceutical Preparations